RE:I wouldn't want... any second now. October 14
mercedesman wrote: ...to miss the opportunity to buy cheap shares before the :
1) closing of the financing (often a bounce when done)
2) announcement (or "leak") of the secret & largest "partner" on the DIMI useability Trial.
3) announcement of the first patient enrollment into the DIMI usablitily Trial (start the count-down)
4) any announcement of an acceleration of Tigris enrollment (expected for this fall due to improved ICU capacities, flu patient prosepcts, additional sites ). Market would then anticipate tranche # 2 form Baxter, and possibly $ form future warrant exercising. Possibly negates need for future financings
5) elucidation of the "strategic partner" that is taking an equity stake for the first time (see debenture financing)
6) confirmation of how full the coffers are looking - post financing. De-risked from a cash flow perspective. Was the raise fully (over?) subscribed ?
7) any new ARC or VA orders/sales (worst case evidenced in Qtrly filings). Offsets need for future financing.
8) possible partial monetization of Dialco in the ST. Will it add cash or marketable securities? Will it improve EDT SP?
MM